Vertex Pharmaceuticals Inc. stock rises Friday, still underperforms market
This was the stock's third consecutive day of gains.
MIT Technology Review5h
Stem-cell therapies that work: 10 Breakthrough Technologies 2025
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.
Levi & Korsinsky Announces an Investigation on Behalf of Vertex Pharmaceuticals Incorporated (VRTX) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
GEN2h
Seven Biopharma Trends to Watch in 2025
GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV – Research Report), Palvella ...
Stocks Rally on Strength in Megacap Tech and Chip Makers
The S&P 500 Index Friday closed up +1.26%, the Dow Jones Industrials Index closed up +0.80%, and the Nasdaq 100 Index closed up +1.67%. March E-mini S&P futures rose +1.17%, and M ...
Regeneron expands eye care focus with Oxular buyout
Regeneron Pharmaceuticals (REGN) expands its focus on eye care with the acquisition of Oxular, a U.K.-based biotech ...